Gene editing and gene therapy platform to treat rare genetic diseases.
(NASDAQ: FIXX)
Location: United States, Massachusetts, Bedford
Employees: 51-200
Total raised: $187M
Founded date: 2015
Investors 4
| Date | Name | Website |
| - | Vida Ventu... | vidaventur... |
| - | 5AM Ventur... | 5amventure... |
| 17.07.2021 | ARCH Ventu... | archventur... |
| - | Vivo Capit... | vivocapita... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 09.11.2020 | - | $60M | - |
| 03.08.2017 | Series B | $83.5M | - |
| 02.05.2016 | Series A | $43.5M | - |
Mentions in press and media 23
| Date | Title | Description | Source |
| 23.04.2024 | Seamless Therapeutics Announces New CEO and Board Chairman t... | DRESDEN, Germany & LEXINGTON, Mass.--(BUSINESS WIRE)-- Seamless Therapeutics today announced the... | forbion.co... |
| 21.10.2021 | Homology Medicines : 10/21/2021 Homology Medicines Announces... | - Data Support PKU and Hunter Syndrome Clinical Trials and PNH Program - BEDFORD, Mass., Oct. 21, 20... | marketscre... |
| 20.10.2021 | Homology Medicines : 10/20/2021 Homology Medicines Announces... | - Oral Presentation on In Vivo Gene Therapy Product Candidate and Data on Gene Editing Candidate Pav... | marketscre... |
| 12.10.2021 | Homology Medicines : 10/12/2021 Homology Medicines Announces... | - IND Clearance of pheEDIT Study to Evaluate a One-Time Dose of Investigational HMI-103 Incorporatin... | marketscre... |
| 13.05.2021 | HOMOLOGY MEDICINES, INC. Homology Medicines : 05/13/2021 Ho... | - Data From New GTx-mAb Platform Demonstrated Proof of Principle for AAVHSCs to Deliver One-Time In ... | marketscre... |
| 06.05.2021 | HOMOLOGY MEDICINES, INC. Homology Medicines : 05/06/2021 Ho... | - On Track to Report Initial Phase 2 Data From pheNIX PKU Clinical Trial by Year End - - Announced N... | marketscre... |
| 07.04.2021 | HOMOLOGY MEDICINES, INC. Homology Medicines : 04/07/2021 Ho... | BEDFORD, Mass., April 7, 2021 - Homology Medicines, Inc. (Nasdaq: FIXX), a clinical-stage genetic me... | marketscre... |
| 01.03.2021 | Homology Medicines Regains Worldwide Rights to Ophthalmology... | - Company plans to continue advancing ophthalmic program toward a development candidate for lead ind... | globenewsw... |
| 09.11.2020 | Homology Medicines Announces $60 Million Equity Investment f... | - | 5amventure... |
| 13.11.2017 | Novartis co-opts Homology's gene-editing tech for R&am... | In the latest move to build up Novartis’ eye drug pipeline, the pharma giant is sinking fresh ... | endpts.com... |
Show more